Dallas, TX -- (ReleaseWire) -- 01/30/2014 -- Over the years, a large number of drug manufacturers have been outsourcing their drug development processes to contract research organizations. Outsourcing activities reduce manufacturing and distribution costs, ensure quality of service, and reduce lead time. They also help the sourcing companies manage product demand and concentrate on other competencies such as innovation and brand building. These contract research organizations employ the latest technologies and sophisticated instruments, and thus increased outsourcing to such organizations is a positive trend driving the market.
According to the report “Biochips Market in North America 2014-2018 - http://www.reportsnreports.com/reports/273329-biochips-market-in-north-america-2014-2018-.html”, one of the main drivers of this market is the increased need for high-speed diagnosis for patients and doctors. Biochips are specially designed with advanced technology that makes them ultra-efficient, thus enhancing their operating speed to a great extent.
The Biochips Market in North America 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report focuses on North America; it also covers the Biochips market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Further, the report states that one of the major challenges is the high cost incurred in the implementation of biochips. The development process of biochips is lengthy as it needs to go through various stages such as design, testing, and implementation. This process is time- consuming and expensive.
Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=273329.
The report recognizes the following companies as the key players in - Biochips Market in North America: Affymetrix Inc., Agilent Technologies Inc., Becton, Dickinson and Co., BioRad Laboratories, Cepheid Inc., Danaher Corp., GE Healthcare Ltd., Microarrays Inc., Qiagen N.V, Promega Corp. Illumina Inc., Life Technologies Corp., Roche Holding AG., Perkin Elmer Inc., and Siemens Healthcare Diagnostics.
Key questions answered in this report:
- What will the market size be in 2018 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?